FDA WARNING_LETTER - Pure Indulgence Aesthetics - December 12, 2025

FDA WARNING_LETTER for Pure Indulgence Aesthetics on December 12, 2025. Product: drugs. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for Pure Indulgence Aesthetics on December 12, 2025. Product: drugs. Access full analysis and detailed observations.

Violation Codes

FD&C Act 582(d)(3)

FD&C Act 503A

FD&C Act 582(d)

21 U.S.C. 360eee-1

FD&C Act 581(3)

FD&C Act 581(7)

FD&C Act 581(14)

FD&C Act 581(20)

FD&C Act 582

FD&C Act 582(c)(3)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Pure Indulgence Aesthetics

Inspection Date

December 12, 2025

Product Type

drugs

Office

Office of Drug Security, Integrity, and Response

People

ID: ef3b3301-e8ad-442b-98c4-a6ed76e2aa76

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox